Early tolerability of Comirnaty vaccine in patients with chronic neurological diseases

Patients with chronic neurological diseases may have predisposing risk factors for severe COVID-19 and should be considered as priority candidates for SARS-CoV-2 vaccination. Nevertheless, the safety of RNA vaccine was evaluated in healthy volunteers or in patients with stable chronic medical condit...

Descripción completa

Detalles Bibliográficos
Autores principales: Budowski, C., Zavanone, C., Thivard, L., Vassilev, K., Dupont, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511656/
https://www.ncbi.nlm.nih.gov/pubmed/34654546
http://dx.doi.org/10.1016/j.neurol.2021.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511656/
https://www.ncbi.nlm.nih.gov/pubmed/34654546
http://dx.doi.org/10.1016/j.neurol.2021.05.005

Ejemplares similares